Clinical Evaluation of Glass Ionomer With Glass Hybrid Technology Versus Conventional High Viscosity Glass Ionomer in Class I Cavities of High Caries Risk Patients
1 other identifier
interventional
31
1 country
1
Brief Summary
PICOTS: P: High Caries Risk Patients with bilateral class I cavities. I: Glass Ionomer with Glass Hybrid Technology. C: Conventional High Viscosity Glass Ionomer. O: Clinical performance (Functional properties Biological properties) using (World Dental Federation) Fédération dentaire internationale (FDI) criteria for dental restorations. T: 1 year. S: Randomized controlled Trial (split mouth design). Research question:In high caries risk patients with class I cavities will glass ionomer with glass hybrid technology has similar clinical performance as conventional high viscosity glass ionomer
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 1, 2016
CompletedFirst Posted
Study publicly available on registry
August 5, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedAugust 5, 2016
August 1, 2016
August 1, 2016
August 2, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical performance using FDI criteria for dental restorations (functional properties and biological properties)
1 year
Study Arms (2)
Glass Ionomer with Glass Hybrid technology
EXPERIMENTALIntervention
Conventional high viscosity Glass Ionomer
ACTIVE COMPARATORComparator
Interventions
Dental restorative material
Dental restorative material
Eligibility Criteria
You may qualify if:
- Bilateral class I carious lesions in their occlusal pits and fissures.
- High caries risk patients who has 1 or more cavitated lesion with risk factor declared by Caries Management By Risk Assessment (CAMBRA)
- Co-operative patients approving to participate in the trial.
You may not qualify if:
- Disabilities.
- Systemic diseases or severe medically compromised.
- Lack of compliance.
- Evidence of severe bruxism, clenching or temporomandibular joint disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of oral and dental medicine, cairo university
Cairo, 11553, Egypt
MeSH Terms
Interventions
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecturer
Study Record Dates
First Submitted
August 1, 2016
First Posted
August 5, 2016
Primary Completion
September 1, 2018
Last Updated
August 5, 2016
Record last verified: 2016-08